Back to the Top
In a study which have five ambulatory samples, a subject is absent for
all the five ambulatory samples in one period but present for all the
ambulatory samples in another period. In PK analysis, whether to
include or delete the subject or is there any regulatory procedure not
to calculate AUCt and AUCinf for that subject?
PharmPK Discussion List Archive Index page
Copyright 1995-2010 David W. A. Bourne (email@example.com)